Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Seneca Foods Shareholders Approve 5-for-1 Stock Split

Seneca Foods Corporation filed an 8-K on November 4, 2026, disclosing the results of a Special Shareholders Meeting held the same day, at which shareholders approved a five-for-one forward stock split and the removal of Preferred Stock Without Par Value from the company's authorized …

Nitish Kishor | 04 November 2026

Omnicell Q3 2026: Net Income Rises to $11.0 Million

Omnicell, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 4, 2026, disclosing financial results for the three and nine months ended on that date.

Nitish Kishor | 04 November 2026

Lesaka Technologies Q1 FY2027: $184.6M Revenue, Net Loss $4.2M

Lesaka Technologies, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 4, 2026, reporting revenue of $184.572 million and a net loss of $4.183 million for the three months ended September 30, 2026.

Anjali Anand | 04 November 2026

Unum Group Q3 2026 10-Q: 154.98M Shares Outstanding

Unum Group filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the Securities and Exchange Commission on November 4, 2026, reporting 154,982,030 shares of common stock outstanding as of November 2, 2026.

Aakashdeep | 04 November 2026

Kailera Therapeutics Files Q3 2026 Report with 129.85M Shares Out

Kailera Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 4, 2026, disclosing its financial position and operational status as a clinical-stage biotechnology company.

Vinay Lochav | 04 November 2026

Design Therapeutics Files $300M Shelf Registration

Design Therapeutics, Inc. filed a Form S-3 shelf registration statement with the U.S. Securities and Exchange Commission on November 4, 2026, covering the potential offering of up to $300,000,000 in securities.

Manish Choudhary | 04 November 2026

Design Therapeutics Files 10-Q for Q3 2026

Design Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the fiscal quarter ended September 30, 2026.

Aakashdeep | 04 November 2026

Fastly President Scott Lovett Plans 2027 Retirement

Fastly, Inc. filed a current report on Form 8-K on November 4, 2026, disclosing that Scott R. Lovett notified the company on October 30, 2026, of his planned retirement as President, Go to Market, on a date to be determined during 2027.

Aditi Sarkar | 04 November 2026

Rapid7 Q3 2026: Net Income $3.5M, Restructuring Charge

Rapid7, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 4, 2026, reporting net income of $3,511 thousand and a restructuring charge of $9,988 thousand for the three months ended September 30, 2026.

Vinay Lochav | 04 November 2026

CODI Launches Consent Solicitation on 2029 and 2032 Senior Notes

Compass Diversified Holdings filed a Form 8-K on November 4, 2026, disclosing a consent solicitation targeting holders of its 5.250% Senior Notes due 2029 and 5.000% Senior Notes due 2032, alongside the announcement of consolidated operating results for the three and nine months ended …

Vinay Lochav | 04 November 2026
Support

Hi! How can we help you today?

Loading…